
Cases in Precision Oncology: Highlights from the 2024 ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series
Tuesday, January 28th, 2025
11:00am-12:00pm ET
www.acmgeducation.net
Course Description
Cases in Precision Oncology: Highlights from the 2024 ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series
This CME Case Series reflects the work of molecular tumor boards by featuring an interdisciplinary discussion of cases that are subject to comprehensive molecular characterization using a variety of advanced technologies. . The molecular characterization of tumor samples ranges from methods on the genomic level to recent advances in proteomics. The field is advancing rapidly, and more and more approaches will translate from basic research to clinical care. In this session, we will summarize the variety of methods described in previous virtual molecular tumor boards and highlight the most interesting cases from 2024. In addition, we will give an outlook on topics to come in 2025.
Target Audience
All medical and healthcare professionals and researchers interested in understanding cancer genomic testing and somatic and germline variant interpretation methods. This series is presented as a collaboration between ClinGen Somatic, VICC, and ACMG consortia.
Agenda
Presentations followed by live Q&A.
Learning Objectives
At the conclusion of this session, participants should be able to:
1. Name three different types of molecular characterization methods.
2. Explain how different types of results can be integrated to benefit a cancer patient.
3. Describe one major challenge in precision oncology.